In vitro culture is the predominant means for isolating and identifying Salmonella species from fecal samples. This is time consuming, usually requiring 72 to 96 h for the organism to be defined by its cultural, biochemical, and serological properties. An alternative method is to detect serum antibodies formed against infecting Salmonella species. The antibodies can be detected by the Widal (tube agglutination) (16) or passive hemagglutination test (10) . These tests are not used routinely due to technique-related insensitivity and nonspecific cross-reactions. However, detection of serum antibodies to Salmonella infections is still theoretically more desirable for mass screening than in vitro culture. The enzyme-linked immunosorbent assay (ELISA) has been developed for a wide variety of antigen-antibody reactions (4, 6, 15), indicating promise for determination of antibody titers to Salmonella infections.
An ELISA test for detection of Salmonella antibodies was described by Carlsson et 
al. (5).
Antibody levels were compared both quantitatively and qualitatively by ELISA, Widal agglutination, passive agglutination, and quantitative precipitation tests. ELISA was the most sensitive test. Later, group-specific antigens were used to stimulate an immune response in rabbits (4) , and serum antibody was measured by the ELISA method. Recently, Salmonella enteritidis and S. typhimurium outbreaks have been diagnosed by ELISA (8, 14) . As yet, researchers and diagnosticians in general have not used the ELISA as a clinical polyvalent test to efficiently screen large numbers of animals for Salmonella antibody titers.
The objective of this investigation was to develop an ELISA for detection of Salmonella species serum antibodies in rodents and evaluate a polyvalent antigen for use in the ELISA. An in vitro serological test of this nature would be highly desirable for diagnostic screening of large numbers of rats and mice in commercial colonies or in research facilities. Since Salmonella serogroups B and D represent a high percentage of Salmonella strains isolated from humans (14) and these serogroups contain nearly all of the strains causing disease in mice and rats (9) , the test was directed against these serogroups. In addition, these studies were intended to examine the possibility of detecting, by ELISA, subclinical infections or carrier states. Furthermore, the potential for false-positives due to cross-reactions with other gut flora was explored and shown to be negligible. (ii) Antisera versus polyvalent antigen.
MATERIALS AND METHODS
Ten positive serum samples from rats experimentally infected with each of the three Salmonella strains were incubated in microtiter plates coated with a mixture of the three antigens (10 ,ug/ml per antigen). The polyvalent ELISA antigen detected every positive serum as determined by that serum's homologous reaction. Negative control sera were also tested with the polyvalent antigen. In three cases, the polyvalent antigen detected positive titers in sera which were negative by the ELISA using the homologous antigen (Table 4) . Two of these sera were collected on day 28 from animals inoculated with a Salmonella species.
DISCUSSION
An ELISA for Salmonella infections of rodents was described before this study (8, 14) . However, the test was not designed as a clinical assay for mass screening of rodents for Salmonella species. The study reported herein presents data on the development of a polyvalent ELISA test for detecting clinical infections and possibly for screening rodent colonies for latent infections. S. typhimurium and S. enteritidis were selected to represent serogroups B and D, which are the most common serogroups isolated in humans (14) and the most important Salmonella pathogens in rats and mice. ELISA. An obvious question of cross-reactions with normal gut flora resulting in invalid tests, poor sensitivity, and poor specificity was answered in this study through use of experimentally infected and hype unized animals. These animals were reared in conventional facilities carrying "normal" intestinal flora (Escherichia coli, Bacteriodes, Pseudomonas, etc.) and demonstrated no cross-reactive interference. The control animals in these studies had a base-line absorbance near zero.
The effectiveness of an ELISA was tested by monitoring experimental infections ( Fig. 1-3) . In all three groups, titers to the organisms were observed between 6 and 11 days for both IgM and IgG, as would be expected. A simple explanation does not exist for the simultaneous rise of IgG and IgM. Typically, the IgM rise should occur 3 to 5 days p.i. However, the introduction of live Salmonella by gastric gavage into normal rats may not invoke a classical immune response. Rats seem to be more resistant than mice to Salmonella infections and generally do not develop clinical disease unless under stress. They frequently become carriers. Data presented in Table 2 substantiate a carrier state or subclinical disease. Many animals continued to shed Salmonella throughout the study without clinical disease, also suggesting that ELISA has the potential to detect Salmonella carriers. The immune response provoked by normal gut flora and carrier state should be similar. Researchers (1, 2, 11) investigating the humoral response to nornal flora admit that the immune response in the gut is not well understood. Attempts have yet to be made in a complete study determining the antibody response of a noninvasive organism. Although the researchers agree that IgM, IgG, and IgA responses are involved (1, 2, 11) , the degree to which each immunoglobulin class asserts itself is controversial. Furthermore, Svenungsson et al. (14) used a polyspecific antiserun and reported very low relative titers to an active infection of S. enteritidis up to 11 days in duration. It is difficult to compare results from another laboratory, but this finding supports our data. These researchers did not specifically determine the initial IgM response, making it difficult to correlate their results with ours. One other possibility for a late IgM response is that the enzyme conjugate was less sensitive. Although possible, this is unlikely since the antiIgM conjugate was prepared similarly and from the same source as the IgG conjugate; in addition, high absorbance values (>1.0) were obtained from sera of infected animals, suggesting a highly sensitive conjugate.
A very important part of developing a clinical test is setting the minimal value to be considered a positive test. ELISA values for negative serum, 25 or more for each Salmonella species, were accumulated, and 2 standard deviations from the mean of these values was at first determined to be our base line. To ascertain the success of the test and the base line, sensitivity and specificity values were calculated. Sensitivity considers the number of false-negatives, and specificity considers the number of false-positives. Ideally, both values should be 90% or above. By moving the base line 0.01 of an absorbance unit higher than 2 standard deviations above the mean, both the sensitivity and specificity were above 95% for S. enteritidis and S. typhimurium. S. rubislaw achieved near the ideal values. Fewer sera were tested in the S. rubislaw system. As more sera are examined, the specificity and sensitivity values for S. rubislaw should rise. Furthermore, the strictest guidelines were maintained for determining the number of true-positives. All sera were considered positive if the animal had been inoculated with the organism, even though the animal at no time had symptoms of disease or shed Salmonella. These animals probably will not seroconvert, yet by our definition they would be considered false-negatives. Due to the expected and observed decline of IgM titers to near zero, specificity and sensitivity values would be of little value and were not determined. In reference to Table 2 , a strong case can be made for ELISA as more sensitive than culture for detection of Salmonella-infected animals. For screening purposes, once the animals seroconvert, the ELISA seems to be superior to culture. However, one must keep in mind that the ELISA is an indirect technique, and confirmation of positives by other methods is suggested.
Antigen was extracted by the water method reported by Roberts (12) . This method is not one of the techniques commonly used to extract lipopolysaccharide. Roberts did an extensive study demonstrating the recovery of the lipopolysaccharide fraction. At any rate, the extract in our work served very well as the antigen and did not seem to cross-react with antibodies formed against normal flora.
Next, a polyvalent antigen was evaluated for use in the ELISA. Each Salmonella antigen was tested against two other Salmonella species antisera to determine if one antigen could provide adequate cross-reactivity and thus avoid the need for a polyvalent antigen (Table 3) . Although all three antigens were recognized in high frequency by heterologous antisera, no antigen was 100% effective. The polyvalent antigen provided a higher degree of sensitivity than any of the three homologous test systems (Table 4) , probably as a result of the cross-reactivity of heterologous antisera (Table 3) . Considering this information, we are assuming that with the correct combination of serogroup antigens, a truly polyvalent Salmonella ELISA will result.
In conclusion, the ELISA described herein provides a high level of sensitivity and specificity and has the potential to become a valuable clinical test. Intestinal flora other than Salmonella species appear not to have interfered with the assay. Our results indicated that an ELISA for quantitating IgG 
